Cardiovasc Diabetol 16:48 Tanaka A, Shimabukuro M, Machii N, Teragawa H, Okada Y, Shima KR, Takamura T, Taguchi I, Hisauchi I, Toyoda S, Matsuzawa Y, Tomiyama H, Yamaoka-Tojo M, Ueda S, Higashi Y, Node K (2020) Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo-controlled double-blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi-center placebo-controlled double-blind randomized trial
The naturally occurring peptide GHK reverses age-related fibrosis by modulating myofibroblast function
Standardised measures were used to identify cases to minimise documentation errors
Forty percent of our business is in emerging markets where I dont think GLP-1s will be embraced
This publication is not a healthcare provider, pharmacy, or licensed medical entity, and nothing in this article creates a doctor-patient, pharmacist-patient, or other professional relationship
10.1159/000460253 Neurodegener